2-135788274-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002299.4(LCT):c.*50G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.833 in 1,361,456 control chromosomes in the GnomAD database, including 477,819 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.78 ( 47297 hom., cov: 32)
Exomes 𝑓: 0.84 ( 430522 hom. )
Consequence
LCT
NM_002299.4 3_prime_UTR
NM_002299.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.108
Genes affected
LCT (HGNC:6530): (lactase) The protein encoded by this gene belongs to the glycosyl hydrolase 1 family of proteins. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme is integral to the plasma membrane and has both phlorizin hydrolase activity and lactase activity. Mutations in this gene are associated with congenital lactase deficiency. Polymorphisms in this gene are associated with lactase persistence, in which intestinal lactase activity persists at childhood levels into adulthood. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 2-135788274-C-G is Benign according to our data. Variant chr2-135788274-C-G is described in ClinVar as [Benign]. Clinvar id is 331159.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.834 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.785 AC: 119278AN: 152034Hom.: 47267 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
119278
AN:
152034
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.796 AC: 195021AN: 244904 AF XY: 0.792 show subpopulations
GnomAD2 exomes
AF:
AC:
195021
AN:
244904
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.839 AC: 1015133AN: 1209306Hom.: 430522 Cov.: 17 AF XY: 0.833 AC XY: 511533AN XY: 613866 show subpopulations
GnomAD4 exome
AF:
AC:
1015133
AN:
1209306
Hom.:
Cov.:
17
AF XY:
AC XY:
511533
AN XY:
613866
Gnomad4 AFR exome
AF:
AC:
19865
AN:
28646
Gnomad4 AMR exome
AF:
AC:
35626
AN:
44404
Gnomad4 ASJ exome
AF:
AC:
13517
AN:
24628
Gnomad4 EAS exome
AF:
AC:
31736
AN:
38610
Gnomad4 SAS exome
AF:
AC:
60694
AN:
81344
Gnomad4 FIN exome
AF:
AC:
39038
AN:
45262
Gnomad4 NFE exome
AF:
AC:
770248
AN:
889956
Gnomad4 Remaining exome
AF:
AC:
41810
AN:
52164
Heterozygous variant carriers
0
8944
17889
26833
35778
44722
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
15396
30792
46188
61584
76980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.785 AC: 119363AN: 152150Hom.: 47297 Cov.: 32 AF XY: 0.782 AC XY: 58170AN XY: 74372 show subpopulations
GnomAD4 genome
AF:
AC:
119363
AN:
152150
Hom.:
Cov.:
32
AF XY:
AC XY:
58170
AN XY:
74372
Gnomad4 AFR
AF:
AC:
0.710879
AN:
0.710879
Gnomad4 AMR
AF:
AC:
0.74784
AN:
0.74784
Gnomad4 ASJ
AF:
AC:
0.546947
AN:
0.546947
Gnomad4 EAS
AF:
AC:
0.802087
AN:
0.802087
Gnomad4 SAS
AF:
AC:
0.747613
AN:
0.747613
Gnomad4 FIN
AF:
AC:
0.869409
AN:
0.869409
Gnomad4 NFE
AF:
AC:
0.839601
AN:
0.839601
Gnomad4 OTH
AF:
AC:
0.725546
AN:
0.725546
Heterozygous variant carriers
0
1294
2588
3882
5176
6470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
868
1736
2604
3472
4340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2701
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Lactose intolerance Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Congenital lactase deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at